S2Medical implements a strategic change to reach profitability faster
In order to reach profitability faster, the company has chosen to implement a strategic change which means that all available resources will be used to achieve increased growth. The company will therefore pause all activities related to R&D and clinical studies. The company's technology for dealing with multi-resistant bacteria will not be affected by this reorganization as that work takes place under external management with the company's university partners and is funded by previously awarded research grants. A consequence of the change is that the overall workforce will decrease